Henry J. Fuchs
2019
Compensation breakdown
| Non-Equity Incentive Plan | $828,000 |
|---|---|
| Option Awards | $1,189,277 |
| Salary | $695,192 |
| Stock Awards | $4,275,463 |
| Other | $29,567 |
| Total | $7,017,499 |
Fuchs received $4.3M in stock awards, accounting for 61% of the total pay in 2019.
Fuchs also received $828K in non-equity incentive plan, $1.2M in option awards, $695.2K in salary and $29.6K in other compensation.
Rankings
In 2019, Henry J. Fuchs' compensation ranked 1,369th out of 13,971 executives tracked by ExecPay. In other words, Fuchs earned more than 90.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,369 out of 13,971 | 90th |
Division Manufacturing | 480 out of 5,695 | 92nd |
Major group Chemicals And Allied Products | 143 out of 2,194 | 94th |
Industry group Drugs | 114 out of 1,880 | 94th |
Industry Pharmaceutical Preparations | 85 out of 1,392 | 94th |
Pay ratio
| Henry J. Fuchs' Pay | $7,017,499 |
|---|---|
| Median Employee's Pay | $190,917 |
| Pay Ratio | 37to 1 |
In 2019, the annual total compensation of Henry J. Fuchs was $7,017,499.
The annual total compensation of the median employee at BioMarin Pharmaceutical was $190,917.
The ratio of Henry J. Fuchs' pay to the pay of median employee was therefore 37 to one.
Fuchs' colleagues
We found five more compensation records of executives who worked with Henry J. Fuchs at BioMarin Pharmaceutical in 2019.
2019
Jean-Jacques Bienaim
BioMarin Pharmaceutical
Chief Executive Officer
2019
Robert Baffi
BioMarin Pharmaceutical
President, Global Manufacturing amp; Technical Operations
2019
Jeff Ajer
BioMarin Pharmaceutical
Executive Vice President, Chief Commercial Officer
2019
Daniel Spiegelman
BioMarin Pharmaceutical
Chief Financial Officer
2019
Brian Mueller
BioMarin Pharmaceutical
Chief Financial Officer
News
April 12, 2022
April 13, 2021
April 14, 2020
April 23, 2019